Interleukin 24 gene therapy (MultiVir)

N/A

Report date: 2023/10/26 16:21:14

Base Information

Drug NameInterleukin 24 gene therapy (MultiVir)

Drug Alias NameIL24 gene therapyAdenoviral interleukin 24Ad-IL-24Ad-IL24

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionInterleukin 24 stimulantsGene transference

TargetsInterleukin 24

Therapy Area/IndicationsHead and Neck NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMultivir Inc

China Registration ClassN/A

Active CompaniesMultivir Inc

Inactive CompaniesN/A

Active IndicationsHead and Neck NeoplasmsMelanoma

Inactive IndicationsN/A

ATC CodeN/A